PHARMACEUTICAL PATENT AND HIV/AIDS

This paper discusses implications of TRIPS Agreement in Tanzania with a special focus on Pharmaceutical Patents and HIV/AIDS. The TRIPS Agreement has brought opportunities for both South and Northern Countries, but it has seemed to benefit more those countries with Patent compared to those with no Patent. The Universal Declaration for human rights points out that the access to public health (health care) is the right of every human being, thus it expose the potential human rights that needs to be considered when implementing TRIPS Agreement in Developing countries. The analysis finds that, protection and enforcement of pharmaceutical process and products in Tanzania will form a basis of charging higher price to the essential drugs and technology transfer hence limits the access of low income earners to these drugs. Moreover, the paper finds that the enforcement of TRIPS in Tanzania will have two major impacts, first patents will show the way to higher drugs prices high hence restrict access to it, secondly, the patents will not promote Research and development on diseases that prevailing in Tanzania.i.e tropical diseases Moreover the findings have showed that those household families who are taking care o